Article Text

Download PDFPDF
Rituximab for tumefactive demyelination refractory to corticosteroids and plasma exchange

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors APS conceived the idea for the article, performed the literature search and wrote the article. EF-R, RS-P and JN-N revised it critically for important intellectual content and gave final approval of the version to be published.

  • Competing interests None.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.